Colony-stimulating factor-1 mediates macrophage-related neural damage in a model for Charcot-Marie-Tooth disease type 1X

Brain

Volumn 135, Issue 1, 2012, Pages 88-104

  Groh, Janos ^a   Weis, Joachim ^b   Zieger, Hanna ^a   Stanley, E Richard ^c   Heuer, Heike ^d   Martini, Rudolf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b RWTH AACHEN UNIVERSITY   (Germany)

^c ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^d FRITZ LIPMANN INSTITUTE   (Germany)

Author keywords

endoneurial fibroblasts; inflammation; myelin, axonopathy; neuromuscular junction

Indexed keywords

BETA GALACTOSIDASE; COLONY STIMULATING FACTOR 1; CONNEXIN 32;

ADULT; ALBERS SCHOENBERG DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL CONTACT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS BREEDING; DEMYELINATION; ELECTRON MICROSCOPY; FEMALE; FIBROBLAST; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGE; MACROPHAGE ACTIVATION; MALE; MOUSE; NERVE BIOPSY; NERVE CELL LESION; NERVE ENDING; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; SCHWANN CELL; SURAL NERVE; UPREGULATION;

EID: 84856746699     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr283     Document Type: Article

References (60)

1. Abe R, Donnelly SC, Peng T, Bucala R, Metz CN. Peripheral blood fibro-cytes: differentiation pathway and migration to wound sites. J Immunol 2001; 166: 7556-62. (Pubitemid 32525636)
2. Berciano J, Garcia A, Calleja J, Combarros O. Clinico- electrophysiological correlation of extensor digitorum brevis muscle atrophy in children with charcot-marie-tooth disease 1A duplication. Neuromuscular disorders: NMD 2000; 10: 419-24. (Pubitemid 30433812)
3. Burns J, Ouvrier RA, Yiu EM, Joseph PD, Kornberg AJ, Fahey MC, et al. Ascorbic acid for Charcot-Marie-Tooth disease type 1A in children: a randomised, double-blind, placebo-controlled, safety and efficacy trial. Lancet Neurol 2009; 8: 537-44.
4. Carenini S, Mäurer M, Werner A, Blazyca H, Toyka KV, Schmid CD, et al. The role of macrophages in demyelinating peripheral nervous system of mice heterozygously deficient in P0. J Cell Biol 2001; 152: 301-308. (Pubitemid 34285600)
5. Carvalho AA, Vital A, Ferrer X, Latour P, Lagueny A, Brechenmacher C, et al. Charcot-Marie-Tooth disease type 1A: clinicopathological correlations in 24 patients. J Peripher Nerv Syst 2005; 10: 85-92. (Pubitemid 40289585)
6. Chitu V, Stanley ER. Colony-stimulating factor-1 in immunity and inflammation. Curr Opin Immunol 2006; 18: 39-48. (Pubitemid 43049646)
7. Court FA, Gillingwater TH, Melrose S, Sherman DL, Greenshields KN, Morton AJ, et al. Identity, developmental restriction and reactivity of extralaminar cells capping mammalian neuromuscular junctions. J Cell Sci 2008; 121: 3901-11.
8. Crawford TO, Griffin JW. Morphometrical and ultrastructural evaluation of the sural nerve in children with Charcot-Marie-Tooth: implication for pathogenesis and treatment. Ann Neurol 1991; 30: 500.
9. D'Antonio M, Feltri ML, Wrabetz L. Myelin under stress. J Neurosci Res 2009; 87: 3241-9.
10. Dai XM, Zong XH, Sylvestre V, Stanley ER. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/Csf1op mice by transgenic expression of cell surface CSF-1. Blood 2004; 103: 1114-23. (Pubitemid 38129579)
11. Fischer S, Kleinschnitz C, Müller M, Kobsar I, Ip CW, Rollins BJ, et al. Monocyte chemoattractant protein-1 is a pathogenic component in a model for a hereditary peripheral neuropathy. Mol Cell Neurosci 2008a; 37: 359-366.
12. Fischer S, Weishaupt A, Troppmair J, Martini R. Increase of MCP-1 (CCL2) in myelin mutant Schwann cells is mediated by MEK-ERK signaling pathway. Glia 2008b; 56: 836-43.
13. Gallardo E, Garcia A, Combarros O, Berciano J. Charcot-Marie-Tooth disease type 1A duplication: spectrum of clinical and magnetic resonance imaging features in leg and foot muscles. Brain 2006; 129: 426-37. (Pubitemid 43164366)
14. Grehl H, Schroder JM. Significance of degenerating endoneurial cells in peripheral neuropathy. Acta neuropathologica 1991; 81: 680-5.
15. Groh J, Heinl K, Kohl B, Wessig C, Greeske J, Fischer S, et al. Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X. Hum Mol Genet 2010; 19: 3530-43.
16. Herzog EL, Bucala R. Fibrocytes in health and disease. Experimental Hematol 2010; 38: 548-56.
17. Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H. The neuroprotective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol 2000; 107: 161-6. (Pubitemid 30347422)
18. Hristova M, Cuthill D, Zbarsky V, Acosta-Saltos A, Wallace A, Blight K, et al. Activation and deactivation of periventricular white matter phagocytes during postnatal mouse development. Glia 2010; 58: 11-28.
19. Huxley C, Passage E, Robertson AM, Youl B, Huston S, Manson A, et al. Correlation between varying levels and the degree of demyelination and reduction in nerve conduction velocity in transgenic mice. Hum Mol Genet 1998; 7: 449-58. (Pubitemid 28120635)
20. Ip CW, Kroner A, Bendszus M, Leder C, Kobsar I, Fischer S, et al. Immune cells contribute to myelin degeneration and axonopathic changes in mice overexpressing proteolipid protein in oligodendro-cytes. J Neurosci 2006a; 26: 8206-16. (Pubitemid 44315145)
21. Ip CW, Kroner A, Fischer S, Berghoff M, Kobsar I, Mäurer M, et al. Role of immune cells in animal models for inherited peripheral neuropathies. Neuromol Med 2006b; 8: 175-89.
22. Joseph NM, Mukouyama YS, Mosher JT, Jaegle M, Crone SA, Dormand EL, et al. Neural crest stem cells undergo multilineage differentiation in developing peripheral nerves to generate endoneurial fibroblasts in addition to Schwann cells. Development 2004; 131: 5599-612. (Pubitemid 39625204)
23. Kalla R, Liu Z, Xu S, Koppius A, Imai Y, Kloss CU, et al. Microglia and the early phase of immune surveillance in the axotomized facial motor nucleus: impaired microglial activation and lymphocyte recruitment but no effect on neuronal survival or axonal regeneration in macrophage-colony stimulating factor-deficient mice. J Comp Neurol 2001; 436: 182-201. (Pubitemid 32622530)
24. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, et al. Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? J Exp Med 1999; 189: 865-70. (Pubitemid 29189691)
25. Kobsar I, Berghoff M, Samsam M, Wessig C, Maurer M, Toyka KV, et al. Preserved myelin integrity and reduced axonopathy in connexin32-deficient mice lacking the recombination activating gene-1. Brain 2003; 126: 804-13. (Pubitemid 36372981)
26. Kohl B, Fischer S, Groh J, Wessig C, Martini R. MCP-1/CCL2 modifies axon properties in a PMP22-overexpressing mouse model for Charcot-Marie-Tooth 1A neuropathy. Am J Pathol 2010; 176: 1390-99.
27. Kondo Y, Adams JM, Vanier MT, Duncan ID. Macrophages counteract demyelination in a mouse model of globoid cell leukodystrophy. J Neurosci 2011; 31: 3610-24.
28. Linker RA, Lee DH, Demir S, Wiese S, Kruse N, Siglienti I, et al. Functional role of brain-derived neurotrophic factor in neuroprotective autoimmunity: therapeutic implications in a model of multiple sclerosis. Brain 2010; 133: 2248-63.
29. Martini R, Fischer S, Lopez-Vales R, David S. Interactions between Schwann cells and macrophages in injury and inherited demyelinating disease. Glia 2008; 56: 1566-77.
30. Mäurer M, Müller M, Kobsar I, Leonhard C, Martini R, Kiefer R. Origin of pathogenic macrophages and endoneurial fibroblast-like cells in an animal model of inherited neuropathy. Mol Cell Neurosci 2003; 23: 351-9. (Pubitemid 36802006)
31. Meyer zu Horste G, Prukop T, Liebetanz D, Mobius W, Nave KA, Sereda MW. Antiprogesterone therapy uncouples axonal loss from demyelination in a transgenic rat model of CMT1A neuropathy. Ann Neurol 2007; 61: 61-72. (Pubitemid 46214245)
32. Micallef J, Attarian S, Dubourg O, Gonnaud PM, Hogrel JY, Stojkovic T, et al. Effect of ascorbic acid in patients with Charcot-Marie-Tooth disease type 1A: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet Neurol 2009; 8: 1103-10.
33. Muller M, Berghoff M, Kobsar I, Kiefer R, Martini R. Macrophage colony stimulating factor is a crucial factor for the intrinsic macrophage response in mice heterozygously deficient for the myelin protein P0. Exp Neurol 2007; 203: 55-62. (Pubitemid 44821163)
34. Nave KA. Myelination and support of axonal integrity by glia. Nature 2010; 468: 244-52.
35. Nelles E, Bützler C, Jung D, Temme A, Gabriel HD, Dahl U, et al. Defective propagation of signals generated by sympathetic nerve stimulation in the liver of connexin32-deficient mice. Proc Natl Acad Sci USA 1996; 93: 9565-70. (Pubitemid 26296648)
36. Niemann A, Berger P, Suter U. Pathomechanisms of mutant proteins in Charcot-Marie-Tooth disease. Neuromolecular Med 2006; 8: 217-42.
37. Ohara S, Takahashi H, Ikuta F. Specialised contacts of endoneurial fibro-blasts with macrophages in wallerian degeneration. J Anatomy 1986; 148: 77-85. (Pubitemid 17172605)
38. Ohno H, Kubo K, Murooka H, Kobayashi Y, Nishitoba T, Shibuya M, et al. A c-fms tyrosine kinase inhibitor, Ki20227, suppresses osteoclast differentiation and osteolytic bone destruction in a bone metastasis model. Molecular Canc Therapeutics 2006; 5: 2634-43. (Pubitemid 44848990)
39. Ohno H, Uemura Y, Murooka H, Takanashi H, Tokieda T, Ohzeki Y, et al. The orally-active and selective c-Fms tyrosine kinase inhibitor Ki20227 inhibits disease progression in a collagen-induced arthritis mouse model. European J Immunol 2008; 38: 283-91.
40. Pareyson D, Reilly MM, Schenone A, Fabrizi GM, Cavallaro T, Santoro L, et al. Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial. Lancet Neurol 2011; 10: 320-8.
41. Pareyson D, Solari A. Charcot-Marie-Tooth disease type 1A: is ascorbic acid effective? Lancet Neurol 2009; 8: 1075-1077.
42. Pennuto M, Tinelli E, Malaguti M, Del Carro U, D'Antonio M, Ron D, et al. Ablation of the UPR-Mediator CHOP restores motor function and reduces demyelination in Charcot-Marie-Tooth 1B Mice. Neuron 2008; 57: 393-405. (Pubitemid 351179164)
43. Peters A, Palay SL, Webster Hd. The fine structure of the nervous system. New York, Oxford: Oxford University Press; 1991.
44. Raivich G, Bohatschek M, Kloss CU, Werner A, Jones LL, Kreutzberg GW. Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 1999; 30: 77-105. (Pubitemid 29331517)
45. Reilly MM, Murphy SM, Laura M. Charcot-Marie-Tooth disease. JPNS 2011; 16: 1-14.
46. Ryan GR, Dai XM, Dominguez MG, Tong W, Chuan F, Chisholm O, et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood 2001; 98: 74-84.
47. Schenone A, Nobbio L, Monti Bragadin M, Ursino G, Grandis M. Inherited neuropathies. Current treatment options in neurology 2011; 13: 160-79.
48. Scherer SS, Wrabetz L. Molecular mechanisms of inherited demyelinating neuropathies. Glia 2008; 56: 1578-89.
49. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle-Nerve 1996; 19: 474-87.
50. Schroder JM, Hoheneck M, Weis J, Deist H. Ethylene oxide polyneurop-athy: clinical follow-up study with morphometric and electron microscopic findings in a sural nerve biopsy. J Neurol 1985; 232: 83-90. (Pubitemid 15059919)
51. Senderek J, Bergmann C, Quasthoff S, Ramaekers VT, Schröder JM. X-linked dominant Charcot-Marie-Tooth disease: nerve biopsies allow morphological evaluation and detection of connexin32 mutations (Arg15Trp, Arg22GIn). Acta Neuropathol 1998; 95: 443-49.
52. Senderek J, Hermanns B, Bergmann C, Boroojerdi B, Bajbouj M, Hungs M, et al. X-linked dominant Charcot-Marie-Tooth neuropathy: clinical, electrophysiological, and morphological phenotype in four families with different connexin32 mutations(1). J Neurological Sci 1999; 167: 90-101. (Pubitemid 29393095)
53. Stoll G, Gabreels-Festen AA, Jander S, Muller HW, Hanemann CO. Major histocompatibility complex class II expression and macrophage responses in genetically proven Charcot-Marie-Tooth type 1 and hereditary neuropathy with liability to pressure palsies. Muscle Nerve 1998; 21: 1419-27. (Pubitemid 28453129)
54. Teitelbaum SL. Bone resorption by osteoclasts. Science 2000; 289: 1504-8.
55. Thomas PK. The deposition of collagen in relation to Schwann cell basement membrane during peripheral nerve regeneration. J Cell Biol 1964; 23: 375-82.
56. Thomas PK. The cellular response to nerve injury. I. The cellular outgrowth from the distal stump of transected nerve. J Anat 1966; 1002: 287-303.
57. Trouvin AP, Goeb V. Receptor activator of nuclear factor-kappaB ligand and osteoprotegerin: maintaining the balance to prevent bone loss. Clinical Interv Aging 2010; 5: 345-54.
58. Uemura Y, Ohno H, Ohzeki Y, Takanashi H, Murooka H, Kubo K, et al. The selective M-CSF receptor tyrosine kinase inhibitor Ki20227 suppresses experimental autoimmune encephalomyelitis. J Neuroimmunol 2008; 195: 73-80.
59. Wei S, Nandi S, Chitu V, Yeung YG, Yu W, Huang M, et al. Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells. J Leukoc Biol 2010; 88: 495-505.
60. Yoshida H, Hayashi S-I, Kunisada T, Ogawa M, Nishikawa S, Okamura H, et al. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 1990; 345: 442-44. (Pubitemid 120014957)